These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 30007283

  • 21. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
    Åkerström T, Willenberg HS, Cupisti K, Ip J, Backman S, Moser A, Maharjan R, Robinson B, Iwen KA, Dralle H, D Volpe C, Bäckdahl M, Botling J, Stålberg P, Westin G, Walz MK, Lehnert H, Sidhu S, Zedenius J, Björklund P, Hellman P.
    Endocr Relat Cancer; 2015 Oct; 22(5):735-44. PubMed ID: 26285814
    [Abstract] [Full Text] [Related]

  • 22. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T, Nakajima Y, Katano-Toki A, Horiguchi K, Matsumoto S, Yoshino S, Yamada E, Tomaru T, Ishii S, Saito T, Ozawa A, Shibusawa N, Satoh T, Okada S, Nagaoka R, Takada D, Horiguchi J, Oyama T, Yamada M.
    Endocr J; 2017 Jan 30; 64(1):39-47. PubMed ID: 27681703
    [Abstract] [Full Text] [Related]

  • 23. Immunohistochemistry of the Human Adrenal CYP11B2 in Normal Individuals and in Patients with Primary Aldosteronism.
    Gomez-Sanchez CE, Gomez-Sanchez EP, Nishimoto K.
    Horm Metab Res; 2020 Jun 30; 52(6):421-426. PubMed ID: 32289837
    [Abstract] [Full Text] [Related]

  • 24. Biochemical, Histopathological, and Genetic Characterization of Posture-Responsive and Unresponsive APAs.
    Guo Z, Nanba K, Udager A, McWhinney BC, Ungerer JPJ, Wolley M, Thuzar M, Gordon RD, Rainey WE, Stowasser M.
    J Clin Endocrinol Metab; 2020 Sep 01; 105(9):e3224-35. PubMed ID: 32516371
    [Abstract] [Full Text] [Related]

  • 25. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
    Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, Usui T, Tagami T, Okuno H, Yamamoto T, Shimatsu A, Katabami T, Okumura A, Kawa G, Tanabe A, Naruse M.
    J Clin Endocrinol Metab; 2013 Apr 01; 98(4):1567-74. PubMed ID: 23443813
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Unilateral diffuse adrenal hyperplasia masquerading as aldosterone-producing adenoma in primary hyperaldosteronism.
    Sasagawa I, Nakada T, Hashimoto T, Kato T, Suzuki H, Ishigooka M, Kubota Y.
    Urol Int; 1993 Apr 01; 50(4):218-22. PubMed ID: 8506594
    [Abstract] [Full Text] [Related]

  • 30. Disordered CYP11B2 Expression in Primary Aldosteronism.
    Gomez-Sanchez CE, Kuppusamy M, Reincke M, Williams TA.
    Horm Metab Res; 2017 Dec 01; 49(12):957-962. PubMed ID: 29202495
    [Abstract] [Full Text] [Related]

  • 31. Expression and functional role of the prorenin receptor in the human adrenocortical zona glomerulosa and in primary aldosteronism.
    Recarti C, Seccia TM, Caroccia B, Gonzales-Campos A, Ceolotto G, Lenzini L, Petrelli L, Belloni AS, Rainey WE, Nussberger J, Rossi GP.
    J Hypertens; 2015 May 01; 33(5):1014-22. PubMed ID: 25668351
    [Abstract] [Full Text] [Related]

  • 32. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
    Azizan EA, Lam BY, Newhouse SJ, Zhou J, Kuc RE, Clarke J, Happerfield L, Marker A, Hoffman GJ, Brown MJ.
    J Clin Endocrinol Metab; 2012 May 01; 97(5):E819-29. PubMed ID: 22442279
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Local Control of Aldosterone Production and Primary Aldosteronism.
    Lalli E, Barhanin J, Zennaro MC, Warth R.
    Trends Endocrinol Metab; 2016 Mar 01; 27(3):123-131. PubMed ID: 26803728
    [Abstract] [Full Text] [Related]

  • 35. miRNA-203 Modulates Aldosterone Levels and Cell Proliferation by Targeting Wnt5a in Aldosterone-Producing Adenomas.
    Peng KY, Chang HM, Lin YF, Chan CK, Chang CH, Chueh SJ, Yang SY, Huang KH, Lin YH, Wu VC, Wu KD.
    J Clin Endocrinol Metab; 2018 Oct 01; 103(10):3737-3747. PubMed ID: 30085132
    [Abstract] [Full Text] [Related]

  • 36. Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates With Aldosterone Production.
    Itcho K, Oki K, Gomez-Sanchez CE, Gomez-Sanchez EP, Ohno H, Kobuke K, Nagano G, Yoshii Y, Baba R, Hattori N, Yoneda M.
    Hypertension; 2020 Feb 01; 75(2):492-499. PubMed ID: 31865789
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
    Rossi GP, Ragazzo F, Seccia TM, Maniero C, Barisa M, Calò LA, Frigo AC, Fassina A, Pessina AC.
    Hypertension; 2012 Aug 01; 60(2):431-6. PubMed ID: 22733469
    [Abstract] [Full Text] [Related]

  • 39. Calneuron 1 Increased Ca2+ in the Endoplasmic Reticulum and Aldosterone Production in Aldosterone-Producing Adenoma.
    Kobuke K, Oki K, Gomez-Sanchez CE, Gomez-Sanchez EP, Ohno H, Itcho K, Yoshii Y, Yoneda M, Hattori N.
    Hypertension; 2018 Jan 01; 71(1):125-133. PubMed ID: 29109191
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.